On November 4, 2021 CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, reported that management will participate in three virtual investor conferences including the Credit Suisse 30th Annual Healthcare Conference taking place November 8-11, 2021, the Evercore ISI 4th Annual HealthCONx Conference taking place November 30 – December 2, 2021 and the Piper Sandler 33rd Annual Virtual Healthcare Conference taking place November 30 – December 2, 2021 (Press release, CymaBay Therapeutics, NOV 4, 2021, View Source [SID1234594491]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Credit Suisse 30th Annual Healthcare Conference
Date: Monday, November 8
Time: 11:20am Eastern Time Fireside Chat
Webcast: View Source

Evercore ISI 4th Annual HealthCONx Conference
Date: Tuesday, November 30
Time: 9:15am Eastern Time Fireside Chat
Webcast: View Source

Piper Sandler 33rd Annual Virtual Healthcare Conference
Date: Thursday, December 2
Time: 10:00am Eastern Time Fireside Chat
Webcast: View Source